MIR8064

Across TCGA pan-cancer cohorts, MIR8064 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MIR8064 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MIR8064 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR8064 expression acts as an unfavorable survival marker, although some lineages such as OV and UCS show a favorable association.

DLBC, PAAD, and UCEC are the cancer types where MIR8064 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	All	0.352	0.859	<.001	105	view →
PAAD	OS	Tertile	All	0.203	0.506	<.001	36	view →
UCEC	DFS	Tertile	All	0.696	0.853	<.001	30	view →
KICH	DFS	Tertile	III,IV	0.035	0.772	.021	18	view →
READ	OS	Tertile	III,IV	0.300	0.801	.003	18	view →
LGG	OS	Tertile	All	0.338	0.543	.012	13	view →
OV	DFS	Tertile	III,IV	0.624	0.511	.032	12	view →
UVM	OS	Tertile	III,IV	0.258	0.633	.024	9	view →
LUSC	DFS	Tertile	III,IV	0.137	0.707	.020	9	view →
UCS	OS	Tertile	II,III,IV	0.690	0.290	.017	8	view →
BRCA	OS	Quartile	All	0.979	0.955	.036	6	view →
SKCM	DFS	Quartile	IV	0.136	0.503	.006	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MIR8064–DLBC (DFS)

Open the DLBC breakdown →